 |
|
|
| |
PAN-GENOTYPIC EVALUATION OF AL-335, A CLINICAL STAGE
URIDINE ANALOG INHIBITOR OF HEPATITIS C VIRUS POLYMERASE
|
| |
| |
Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
J. Deval, A. Fung, I. Behera, Z. Jin, C.A. Jekle, A. Stoycheva, L.M. Blatt,
G. Wang, N. Dyatkina, M. Prhavc, J.A. Symons, D.B. Smith, L. Beigelman
Alios BioPharma, Inc., part of the Janssen Pharmaceutical Companies, South San Francisco, CA, USA.
|
| |
|
|
|
|
|
